“
“”"Standardization and organoleptic and physicochemical characterization of 15 Argentinean Propofis”". Propolis is a mixture of complex chemical composition that possesses biological properties of great MLN2238 nmr interest for therapeutic purposes. Different types of propolis exist, which differ in its chemical composition according to its botanical origin. At present, there is not a quality standard for propolis. For this reason, in this work the organoleptic characteristics, the physicochemical properties, the total content of
phenolic compounds and the flavonoid composition of 15 samples of propolis collected from different regions of Chaco, Corrientes, Santiago del Estero, and Mendoza were determined, for providing an standardization that allows the production of effective and safe propolis products. It was found great variation in the properties of the different studied propolis, even of those from the same region. Principally, propolis differed in its phenolic and flavonoids content, being significantly higher in propolis from Mendoza, where the most abundant vegetation belongs to Popular sp.”
“There exists a huge gap between protocols issued by scientific bodies and evidence derived by system biology studies on the multifactorial
origin of threatened preterm delivery and their different associations with neonatal outcome. The objective of this prospective study was the analysis obstetrical and neonatal outcome in a cohort of pregnant patients treated for the risk of preterm delivery according to maternal and fetal assessment determined by PF477736 mouse amniotic fluid samples. Methods. Threatened preterm delivery and premature rupture of membranes between 24 + 1 and 32 + 6 weeks of gestation were treated by prolonged tocolytic regimens and if necessary by antibiotics for maternal
infections when intra-amniotic inflammation (IAI) was excluded on the basis of negative white blood cell count in the amniotic fluid, or opposite, by delivery after a course of betamethasone and 48 hours maintenance tocolysis. Twenty-three cases were compared with 22 historical controls treated by the same teams according to the 48 hours treat and wait criteria. In addition to this, cases with normal and abnormal amniotic Selleckchem Selumetinib fluid white blood cell were compared. Results. Maternal and fetal conditions at admission were not significantly different between the study and control cohort for all maternal and fetal variables. Clinical indices were significantly improved as regard to latency from admission to delivery, number of newborns admitted to neonatal intensive care unit and length of stay in neonatal intensive care unit. Not any perinatal death or sepsis occurred in the study cohort. Overall, improved neonatal outcomes were observed in the study cohort. Composite major neonatal eventuful outcomes occurred in 26% of cases vs. 50% in controls.